Allopregnanolone
(Synonyms: 四氢孕酮) 目录号 : GC14192
Allopregnanolone 是一种 3alpha、5alpha 孕酮代谢物，可作为 γ-氨基丁酸 A 型 (GABAA) 受体的有效变构调节剂，发挥抗抑郁和神经保护作用 。
Cas No.:516-54-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Allopregnanolone, a 3alpha, 5alpha progesterone metabolite, acts as a potent allosteric modulator of the γ-aminobutyric acid type A (GABAA) receptor, exerts antidepressant and neuroprotective action [1]. The levels of this neuroactive steroid as well as its effects are sexdimorphic [2].
Allopregnanolone (3 μM) present in the culture medium for 5 days did not change the amount of active, phosphorylated form of protein kinase B (PKB, Akt) and extracellular signal-regulated kinase (ERK). Allopregnanolone and THDOC inhibited basal and forskolin-induced CRH gene promoter activity in the differentiated Neuro-2A cells [1].
Allopregnanolone treatment exerted protective effects also in experimental models of neurodegeneration. For instance, Allopregnanolone(2 mg/kg, i.p.) is protective against kainic acidinduced excitotoxicity in the hippocampus in vivo [3]. In the nucleus accumbens of learned helplessness rats (i.e., an experimental model of depression) the astroglial glutamate transporter-1 and glutamine synthetase system is normalized by Allopregnanolone treatment [4]. In mood and anxiety disorders, Allopregnanolone (3 mg/kg and 1 mg/kg, s.c) treatment shows sex specific features. This neuroactive steroid attenuates in females, but not in males, the HPA axis responses to interleukin-1β in adult prenatally stressed rats [5].
References:
[1]. Budziszewska B, Zaj?c A, Basta-Kaim A, et al. Effects of neurosteroids on the human corticotropin-releasing hormone gene[J]. Pharmacological Reports, 2010, 62(6): 1030-1040.
[2]. Diviccaro S, Cioffi L, Falvo E, et al. Allopregnanolone: An overview on its synthesis and effects[J]. Journal of Neuroendocrinology, 2022
[3]. Ciriza I, Carrero P, Frye C A, et al. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective[J]. Journal of neurobiology, 2006, 66(9): 916-928.
[4]. Nangaku M, Yoshino K, Oda Y, et al. Astroglial glutamate transporter 1 and glutamine synthetase of the nucleus accumbens are involved in the antidepressant-like effects of allopregnanolone in learned helplessness rats[J]. Behavioural Brain Research, 2021, 401: 113092.
[5]. Brunton P J, Donadio M V, Yao S T, et al. 5α-Reduced neurosteroids sex-dependently reverse central prenatal programming of neuroendocrine stress responses in rats[J]. Journal of Neuroscience, 2015, 35(2): 666-677.
Allopregnanolone 是一种 3alpha、5alpha 孕酮代谢物，可作为 γ-氨基丁酸 A 型 (GABAA) 受体的有效变构调节剂，发挥抗抑郁和神经保护作用 [1]。这种神经活性类固醇的水平及其作用是两性异形的[2]。
在培养基中存在 5 天的四氢孕酮 (3 μM) 并未改变活性磷酸化形式的蛋白激酶 B（PKB、Akt）和细胞外信号调节激酶 (ERK) 的数量。 Allopregnanolone 和 THDOC 抑制分化的 Neuro-2A 细胞中基础和毛喉素诱导的 CRH 基因启动子活性[1]。
Allopregnanolone 治疗也在神经变性实验模型中发挥保护作用。例如，Allopregnanolone（2 mg/kg，i.p.）在体内可防止红藻氨酸诱导的海马体兴奋性毒性[3]。在习得性无助大鼠（即抑郁症实验模型）的伏隔核中，星形胶质细胞谷氨酸转运体 1 和谷氨酰胺合成酶系统通过四氢孕酮治疗[4] 正常化。在情绪和焦虑障碍中，Allopregnanolone（3 mg/kg 和 1 mg/kg，皮下注射）治疗显示出性别特异性特征。这种具有神经活性的类固醇会减弱成年产前应激大鼠中 HPA 轴对白细胞介素 1β 的反应，但在雌性中不会减弱 [5]。
| Cell experiment [1]: | |
|
Cell lines |
Stably transfected differentiated Neuro-2A cells |
|
Preparation Method |
Stably transfected differentiated Neuro-2A cells, at final confluence of about 80%, were treated with vehicle, Allopregnanolone, THDOC, PGL, PGL-S, DHEA, DHEA-S at concentrations from 0.01 to 30 µM for 5 days. Next, the influence of all the above-listed neurosteroids at the same concentrations (0.01-30 µM) present in the medium for 5 days, on forskolin-stimulated CAT activity was measured in Neuro-2A cells. Forskolin (25µM) was added to the culture medium 24 h before harvesting of the cells. |
|
Reaction Conditions |
0.01 to 30 µM for 5 days |
|
Applications |
Allopregnanolone and THDOC treatment inhibited in a concentration-dependent manner (1-30 µM) against the CRR-CAT activity. Lower concentrations of Allopregnanolone and THDOC (0.01-0.3 µM) were inactive. |
| Animal experiment [2]: | |
|
Animal models |
Female Sprague Dawley rats |
|
Preparation Method |
To test whether suppressed HPA axis responses to IL-1β could be mimicked in virgin rats with allopregnanolone treatment, blood samples and brains were collected from virgin rats treated with allopregnanolone (3 and 1 mg/kg, s.c., 20 and 2 h before IL-1β, respectively) or vehicle (15% ethanol in corn oil; 0.5 ml/kg). To verify that the effects of finasteride on HPA responses to IL-1β seen in pregnant rats were attributable to the actions of allopregnanolone, blood samples and brains were also collected from pregnant (day 20-21) rats treated with finasteride and either allopregnanolone or vehicle. |
|
Dosage form |
3 and 1 mg/kg, s.c. |
|
Applications |
There was a significant effect of allopregnanolone treatment on ACTH secretion in the virgin rats. There was no difference in basal plasma ACTH concentration between vehicle and allopregnanolone-pretreated virgin rats . IL-1β significantly increased ACTH secretion within 15 min in both the vehicle-treated virgins (4.0-fold increase) and the allopregnanolone treated virgins (2.0-fold increase); the response was markedly reduced in the allopregnanolone-treated group (57% of the peak response in the vehicle group). |
|
References: [1] :Budziszewska B, Zając A, Basta-Kaim A, et al. Effects of neurosteroids on the human corticotropin-releasing hormone gene[J]. Pharmacological Reports, 2010, 62(6): 1030-1040. [2] :Brunton P J, McKay A J, Ochędalski T, et al. Central opioid inhibition of neuroendocrine stress responses in pregnancy in the rat is induced by the neurosteroid allopregnanolone[J]. Journal of Neuroscience, 2009, 29(20): 6449-6460. |
|
| Cas No. | 516-54-1 | SDF | |
| 别名 | 四氢孕酮 | ||
| 化学名 | 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone | ||
| Canonical SMILES | O[C@H]1C[C@H]2[C@@](CC1)(C)[C@@H]3[C@@H](CC2)[C@H]4[C@]([C@@H](C(C)=O)CC4)(C)CC3 | ||
| 分子式 | C21H34O2 | 分子量 | 318.49 |
| 溶解度 | Acetonitrile: 1 mg/ml,Ethanol: 1 mg/ml,Methanol: 1 mg/ml | 储存条件 | Store at RT |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 3.1398 mL | 15.6991 mL | 31.3982 mL |
| 5 mM | 0.628 mL | 3.1398 mL | 6.2796 mL |
| 10 mM | 0.314 mL | 1.5699 mL | 3.1398 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet